M05.062 Felty's syndrome, left knee

Name of the Condition

• Felty's syndrome, left knee

Summary

Felty's syndrome is a rare complication of rheumatoid arthritis characterized by the triad of rheumatoid arthritis, splenomegaly (enlarged spleen), and neutropenia (low neutrophil count). When affecting the left knee, it involves chronic inflammation of the left knee joint alongside systemic manifestations. The condition typically occurs in individuals with long-standing, severe rheumatoid arthritis and is associated with increased susceptibility to infections due to neutropenia.

Causes

Felty's syndrome is considered a variant of rheumatoid arthritis, though its exact cause is not fully understood. It is thought to result from chronic inflammation and immune dysregulation, leading to splenic sequestration of neutrophils and bone marrow suppression. The condition is strongly associated with high titers of rheumatoid factor and anti-citrullinated protein antibodies (ACPA). Left knee involvement occurs as part of the broader rheumatoid arthritis process affecting multiple joints.

Risk Factors

• Long-standing, severe rheumatoid arthritis
• High titers of rheumatoid factor
• Presence of anti-citrullinated protein antibodies (ACPA)
• Advanced age (typically over 50 years)
• Female gender (more commonly affected)

Symptoms

• Persistent joint pain, swelling, and stiffness in the left knee from underlying rheumatoid arthritis
• Fatigue and weakness
• Recurrent infections due to neutropenia
• Abdominal discomfort or fullness from splenomegaly
• Unexplained weight loss
• Skin discoloration or ulcers (less common)

Diagnosis

Diagnosis of Felty's syndrome with left knee involvement requires confirmation of the triad of rheumatoid arthritis, splenomegaly, and neutropenia, along with evidence of left knee inflammation. Clinical evaluation includes assessing joint symptoms, splenic size, and blood counts. Laboratory tests may show elevated inflammatory markers, rheumatoid factor, and ACPA. Imaging of the left knee (e.g., X-ray or MRI) can confirm joint damage, while ultrasound or CT may assess splenomegaly. Bone marrow biopsy is rarely needed but may be considered if bone marrow suppression is suspected.

Treatment Options

Treatment focuses on managing rheumatoid arthritis and its complications. Disease-modifying antirheumatic drugs (DMARDs) are first-line to control inflammation. Biologic agents (e.g., TNF inhibitors) may be used for refractory cases. Granulocyte colony-stimulating factor (G-CSF) can address neutropenia and reduce infection risk. Splenectomy is rarely performed. Knee-specific interventions include physical therapy, analgesics, and intra-articular corticosteroids for pain relief. Infections require prompt antibiotic treatment.

Prognosis and Follow-Up

Prognosis depends on disease severity and response to treatment. Early intervention with DMARDs can improve outcomes, but long-standing disease may lead to joint damage and increased infection risk. Regular monitoring of blood counts, joint function, and splenic size is essential. Follow-up includes rheumatology and primary care visits to adjust therapies and address complications.

Complications

• Increased susceptibility to severe infections due to neutropenia
• Progressive joint damage in the left knee, leading to disability
• Splenic rupture (rare)
• Anemia or thrombocytopenia (additional cytopenias)
• Vasculitis or other extra-articular manifestations of rheumatoid arthritis

Lifestyle & Prevention

• Adhere to prescribed rheumatoid arthritis medications to control inflammation
• Practice good hygiene to reduce infection risk
• Engage in low-impact exercises to maintain joint mobility
• Monitor for signs of infection and seek prompt care
• Avoid smoking, which worsens rheumatoid arthritis outcomes

When to Seek Professional Help

Seek immediate medical attention for:

• Fever or signs of infection (e.g., chills, cough)
• Sudden severe left knee pain or swelling
• Unexplained bruising or bleeding (signs of thrombocytopenia)
• Abdominal pain (possible splenic enlargement or rupture)

Tips for Medical Coders

Document the left knee involvement and confirm the triad of rheumatoid arthritis, splenomegaly, and neutropenia to support the diagnosis. Ensure clinical notes specify the affected joint and systemic manifestations. Code M05.062 is specific to Felty's syndrome with left knee involvement; do not use this code for bilateral or unspecified knee involvement. Verify that documentation aligns with the ICD-10-CM coding guidelines for site-specific conditions.